thymol has been researched along with Mastitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Y; Fu, Y; Guo, M; Li, D; Li, F; Liang, D; Song, X; Wang, T; Wang, W; Yang, Z; Zhang, N; Zhou, E | 1 |
| Anderson, KL; Barlow, BM; Baynes, RE; Mason, SE; McPhee, CS; Yeatts, JL | 1 |
2 other study(ies) available for thymol and Mastitis
| Article | Year |
|---|---|
Thymol inhibits LPS-stimulated inflammatory response via down-regulation of NF-κB and MAPK signaling pathways in mouse mammary epithelial cells.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Cell Survival; Cells, Cultured; Cyclooxygenase 2; Down-Regulation; Epithelial Cells; Extracellular Signal-Regulated MAP Kinases; Female; I-kappa B Proteins; Inflammation; Interleukin-1beta; Interleukin-6; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Macrophages; Mammary Glands, Animal; MAP Kinase Signaling System; Mastitis; Mice; Mice, Inbred BALB C; NF-KappaB Inhibitor alpha; Nitric Oxide Synthase Type II; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Thymol; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2014 |
Milk and plasma disposition of thymol following intramammary administration of a phytoceutical mastitis treatment.
Topics: Angelica sinensis; Animals; Anti-Infective Agents, Local; Dairying; Drug Administration Routes; Drug Residues; Female; Gaultheria; Glycyrrhiza uralensis; Goats; Mammary Glands, Animal; Mastitis; Milk; Phytotherapy; Pilot Projects; Thymol; Thymus Plant | 2011 |